The aim of this study is to show that early identification of PTSD and CPTSD would increase recognition of these disorders and facilitate diagnosis, referral and recovery.
Between 61% and 81% of men and 51% to 74% of women are exposed to a traumatic event in their lifetime. These events may be brief and discrete, prolonged and/or recurrent, and may be direct or indirect. Direct or indirect exposure to traumatic events can lead to serious negative psychological consequences, including post-traumatic stress disorder (PTSD) and complex post-traumatic stress disorder (CPTSD). People exposed to complex traumatic events are at risk not only of suffering from PTSD or Complex PTSD, but also from other mental health co-morbidities, such as substance use disorders (drugs, alcohol, benzodiazepine misuse) , often associated with the repetition of situations of interpersonal violence from which it is difficult, if not impossible, to escape. Caring for people suffering from psychological trauma is a major public health issue. However, there are no good clinical practice guidelines for diagnosis, assessment and treatment, which would enable good practice to be standardised and disseminated. The prevention, detection, early support and appropriate guidance of people suffering from post-traumatic sequelae promote their recovery and improve their quality of life. The World Health Organization (WHO) refers to this as psychological distress, and points out that if it is not properly identified or accompanied, it can tip a person into illness or increase social difficulties. When it is temporary and follows a stressful event, it is considered a normal adaptive reaction. On the other hand, when it becomes intense and persistent, it may be an indicator of a psychological disorder. The public health challenge associated with PTSD is to better recognise, diagnose and treat it, as it can have serious consequences for the quality of life, social functioning and suicide risk of those affected. The aim of this study is to show that early identification of PTSD and CPTSD would increase recognition of these disorders and facilitate diagnosis, referral and recovery. It would also make it possible to provide individualised support for patients and improve their quality of life.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Patients questionnaires, on paper and data collection on patients medical file
Medical and Psychological Centre - Novo Hospital - Site Beaumont-sur-Oise
Beaumont-sur-Oise, France
Medical and Psychological Centre - Isarien Hospital Centre
Clermont, France
Assessment of the proportion of Post-Traumatic Stress Disorder (PTSD) in patients with substance use disorders
Percentage of patients with PTSD among those with substance use disorders Patients with PTSD will be identified using the International Trauma Questionnaire (ITQ) : A diagnosis of PTSD requires the presence of at least one symptom in each of the following dimensions * P1 or P2 ≥ 2 * P3 or P4 ≥ 2 * 5 or P6 ≥ 2 AND * P7 or P8 or P9 ≥ 2 Score ITQ for PTSD : ≥ 8
Time frame: At the end of the study, an average of 12 month
Distinguishing between the prevalence of Post-Traumatic Stress Disorder (PTSD) and Complex Post-Traumatic Stress Disorder (CPTSD)
Percentage of patients with CPTSD among those with substance use disorders Patients with CPTSD will be identified using the International Trauma Questionnaire (ITQ) : A diagnosis of CPTSD requires a PTSD : ≥ 8 and, at least, one symptom in each of the dimensions of disturbance of self-organisation * C1 or C2 ≥ 2 * C3 or C4 ≥ 2 * C5 or C6 ≥ 2 AND * C7 or C8 or C9 ≥ 2 Score ITQ for CPTSD : ≥ 16
Time frame: At the end of the study, an average of 12 month
Identification of risk factors by comparing demographic data of PTSD versus CPTSD patients
Risk factors will be identified from the demographic data collected via the patient characteristics questionnaire between PTSD and CPTSD patients
Time frame: At the end of the study, an average of 12 month
Identification of the pathologies most associated with PTSD and CPTSD
The pathologies most frequently associated with PTSD and CPTSD will be identified by collecting the pathologies present in the medical records of all patients.
Time frame: At the end of the study, an average of 12 month
Comparison of the time between management and identification of patients with PTSD versus CPTSD
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Comparison for number of days between the start of treatment for substance use disorders and the identification of PTSD or CPTSD
Time frame: At the end of the study, an average of 12 month